Press Releases

Page:
  • 1

Gyroscope Therapeutics announces first patient dosed in Phase I/II FOCUS study in dry AMD

19th February 2019 by Sarah Neale PDF Document
Download

Gyroscope Therapeutics led consortium secures INNOVATE UK funding to develop a suspension platform for cost effective manufacture of novel AAV gene therapies

14th November 2018 by Sarah Neale PDF Document
Download

Gyroscope Therapeutics appoints Dr Soraya Bekkali as Chief Executive Officer

20th September 2017 by admin PDF Document
Download